Monday, October 5, 2026

AI Infrastructure Stocks Surge 166-315% While Software Names Tumble in Market Split

SanDisk stock jumped 315.3% and Western Digital surged 166.1% as investors dump AI software stocks and pile into hardware. Micron Technology posted record Q1 2026 revenues with margin expansion while two firms announced $400 billion in infrastructure spending. The bifurcation separates speculative AI plays from companies building the physical backbone.

AI Infrastructure Stocks Surge 166-315% While Software Names Tumble in Market Split
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

SanDisk stock gained 315.3% and Western Digital shares surged 166.1% as a sharp divide opened between AI infrastructure providers and software companies in recent months. The rally in storage and chip makers contrasts with what analysts describe as an indiscriminate sell-off hitting AI software and tech services stocks.

Micron Technology reported record revenues and expanding margins in its Q1 fiscal 2026 results, underscoring strong demand for memory chips powering AI systems. The performance highlights how hardware suppliers are capturing investor confidence while application-layer companies face skepticism about monetization.

Two companies recently announced $400 billion in combined capital expenditures for AI infrastructure. Nebius separately disclosed plans for $16-20 billion in capex, with 60% funded from operating cash flow. The spending wave targets data centers, chips, and storage rather than software development.

Price-to-earnings ratios between hardware and software segments show widening gaps. Infrastructure companies trade at lower multiples despite revenue growth, while software stocks carry premium valuations that investors now question. Capital flows reflect this reassessment, with money moving from speculative AI applications to tangible infrastructure assets.

The market correction separates companies with physical products and predictable revenue from those promising future AI capabilities. Storage makers benefit from immediate demand as data centers expand. Chip manufacturers see orders locked in through long-term contracts. Software firms must prove their AI features generate sustainable income.

Analysts tracking the 6-12 month performance window note infrastructure stocks outpacing software by triple-digit percentages. The trend suggests investors now favor proven hardware economics over software growth stories. Companies building servers, chips, and storage infrastructure attract capital that previously chased AI application developers.

The bifurcation creates two distinct valuation environments. Infrastructure providers trade on tangible metrics like fab capacity and chip output. Software companies face scrutiny over user adoption and pricing power. This split may persist until AI applications demonstrate clear paths to profitability matching their earlier hype.

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com